PATENT CLAIM ANALYSIS

Application Number: 15762050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "209100"]

Abstract:
Provided herein are optimized, recombinant influenza HA polypeptides that elicit immune responses. Also provided are compositions and kits comprising the optimized HA polypeptides as well as methods of making and using the optimized HA polypeptides.

Claim (Index 11):
The virus-like particle of  claim 10 , wherein the wherein the amino acid sequence of the influenza NA polypeptide is at least 95% identical to SEQ ID NO:27, the amino acid sequence of the influenza M1 polypeptide is at least 95% identical to SEQ ID NO:29, or both.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 1.40741
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14388726', '15051991', '15392710', '14377633', '14376689']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7879987119140742
- 35 USC 102 Novelty (BERT): 0.5355303197069234
- Combined Prediction Score: 0.7627518726933592
- Mean Citation Score: 368.001672
- Max Citation Score: 375.28708
- Similarity Product: 274.66746028298854

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test